Browsing by Author BRUCHERTSEIFER FRANK

Showing results 21 to 40 of 92 < previous   next >
Publication YearJRC N°TitleAuthor(s), Editor(s), Other Contributor(s)Publication Type
2017JRC106151Correspondence between alpha-particle emitter dosimetry and normal organ toxicityJOSEFSSON ANDERS; NEDROW JESSIE; HOBBS ROBERT F.; BAECK TOM; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS GEORGEArticles in periodicals and books
2019JRC113789Development and dosimetry of Pb-203 / Pb-212 labeled PSMA ligands – Bringing “the Lead” into PSMA-Targeting Alpha Therapy?KRATOCHWIL CLEMENS; DOS SANTOS JOSE CARLOS; LEHNERT WENCKE; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; HABERKORN UWE; KOPKA KLAUS; MIER WALTERArticles in periodicals and books
2008JRC44967Development and Evaluation of Peptidic Ligands Targeting Tumor-associated Urokinase Plasminogen Activator Receptor (uPAR) for Use in Alpha-emitter Therapy of Disseminated Ovarian CancerKNOER S.; SATO S.; HUBER T.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHMITT M.; KESSLER H.; SENEKOWITSCH-SCHMIDTKE R.; MAGDOLEN V.; SEIDL C.Articles in periodicals and books
2019JRC120174Development of Targeted Alpha Therapy from Bench to BedsideMORGENSTERN ALFRED; BRUCHERTSEIFER FRANKArticles in periodicals and books
2019JRC113165DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assaySCHMEISER HEINZ; MUEHLBAUER KARL-RUDOLPH; MIER WALTER; BARANSKI ANN-CHRISTIN; NEELS OLIVER; DIMITRAKOPOULOU-STRAUSS ANTONIA; SCHMEZER PETER; KRATOCHWIL CLEMENS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED, et alArticles in periodicals and books
2019JRC113164Drugs that modify cholesterol metabolism alter the p38/JNK-mediated targeted and nontargeted response to alpha and Auger radioimmunotherapyLADJOHOUNLOU RIAD; LOZZA CATHERINE; PICHARD ALEXANDRE; CONSTANZO JULIE; KARAM JIHAD; LE FUR PIERRE; DESHAYES EMMANUEL; BOUDOUSQ VINCENT; PAILLAS SALOME; BUSSON MURIEL, et alArticles in periodicals and books
2018JRC106081Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in RadiotherapyWURZER A; SEIDL C.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; SCHWAIGER MARKUS; WESTER HANS-JÜRGEN; NOTNI JOHANNESArticles in periodicals and books
2018JRC112882Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: Towards improved alpha-therapeuticsŠIMEČEK JAKUB; HERMANN PETR; SEIDL C.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; WESTER HANS-JÜRGEN; NOTNI JOHANNESArticles in periodicals and books
2018JRC111783Enhancing Targeted α-therapy for treatment of metastatic breast cancerNEDROW JESSIE; MCCARTY GREG; JOSEFSSON ANDERS; RAY SANGEETA; CORTEZ ANGEL; SONG HONG; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.Articles in periodicals and books
2018JRC107697Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α‑Particle Therapy of CancerPRUSZYNSKI MAREK; D'HUYVETTER MATTHIAS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; LAHOUTTE TONYArticles in periodicals and books
2018JRC109089Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapyCEDROWSKA EDYTA; PRUSZYNSKI MAREK; MAJKOWSKA PILIP AGNIESZKA; MECZYNSKA-WIELGOSZ SYLWIA; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; BILEWICZ ALEKSANDERArticles in periodicals and books
2007JRC41945Gemcitabine Radiosensitizes Multiple Myeloma Cells to Low LET, but not High LET, IrradiationSUPIOT S.; THILLAYS F.; RIO E.; GOUARD S.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; MAHE M. A.; CHATAL J. F.; DAVODEAU F.; CHEREL M.Articles in periodicals and books
2017JRC106152The impact of tumor burden on the absorbed dose to the kidneys from Actinium-225 labeled antibody therapy in a murine model and predicted dosimetric impact for human clinical useJOSEFSSON ANDERS; NEDROW JESSIE; PARK SUNJU; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED; SGOUROS G.; HOBBS ROBERT F.Articles in periodicals and books
2017JRC103932Improved 225Ac daughter retention in InPO4 containing polymersomesDE KRUIJFF R. M.; DROST K; THIJSSEN L; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; LATHOUWERS D.; WOLTERBEEK H.TH.; DENKOVA A.G.Articles in periodicals and books
2007JRC37786An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha TherapyZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2019JRC116487Improved tumor control and absence of late neurotoxicity using alpha (213Bi) as compared to beta (90Y) labelled-DOTA-Substance P for the treatment of low grade gliomasMERLO A.; KROLICKI LESZEK; CORDIER D.; BRUCHERTSEIFER FRANK; MORGENSTERN ALFREDArticles in periodicals and books
2017JRC105936In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapyCHAN HO SZE; DE BLOIS ERIK; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; DE JONG MARION; BREEMAN W.A.P.; KONIJNENBERG M.W.Articles in periodicals and books
2018JRC109759In vitro evaluation of 225Ac-DOTA-Substance P for targeted alpha therapy of glioblastoma multiformeMAJKOWSKA PILIP AGNIESZKA; RIUS MONTRAVETA MARIA; BRUCHERTSEIFER FRANK; APOSTOLIDIS CHRISTOS; WEIS MIRJAM; BONELLI MILTON; LAURENZA MARTA; KROLICKI LESZEK; MORGENSTERN ALFREDArticles in periodicals and books
2019JRC116650The in vivo fate of 225Ac daughter nuclides using polymersomes as a model carrierDE KRUIJFF R. M.; RAAVE R; KIP ANNEMARIE; MOLKENBOER- KUENEN JANNIKE; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; HESKAMP SANDRA; DENKOVA A.G.Articles in periodicals and books
2019JRC112045Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing 225Ac-PSMA-617 RLTRATHKE H; KRATOCHWIL CLEMENS; HOHENBERG RALPH; GIESEL FREDERIK; BRUCHERTSEIFER FRANK; FLECHSIG PAUL; MORGENSTERN ALFRED; HEIN MATTI; PLINKERT PETER; HABERKORN UWE, et alArticles in periodicals and books